Clinical Trials Directory

Trials / Completed

CompletedNCT05631197

Biomimetic Hydroxyapatite in Pediatric Patients With Asthma and/or Allergic Rhinitis

Biomimetic Hydroxyapatite vs Fluoride for the Domiciliary Oral Hygiene of Pediatric Patients With Asthma and/or Allergic Rhinitis: Randomized Clinical Trial

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
40 (actual)
Sponsor
University of Pavia · Academic / Other
Sex
All
Age
6 Years – 14 Years
Healthy volunteers
Not accepted

Summary

The aim of the study is to compare the incidence of dental caries and the level of demineralization in pediatric patients with asthma and/or allergic rhinitis. Patients will conduct professional oral hygiene at the baseline. The following clinical indexes will be assessed: BEWE Index, Plaque Index, Bleeding Score, Schiff Air Index. Then, patients will be randomly divided into two groups: * Trial group: domiciliary use of Biorepair Total Protection Plus + desensitizing enamel-repair shock treatment twice a day * Control group: domiciliary use of Elmex Caries Protection twice a day The clinical indexes will be assessed again after 1 month (T1), after 3 (T2) and 6 months (T3).

Conditions

Interventions

TypeNameDescription
OTHERBiorepair Total Protection Plus + desensitizing enamel-repair shock treatmentDomiciliary use twice a day
OTHERSensodyne Repair & ProtectDomiciliary use twice a day

Timeline

Start date
2022-03-02
Primary completion
2023-09-27
Completion
2023-09-30
First posted
2022-11-30
Last updated
2023-11-08

Locations

1 site across 1 country: Italy

Source: ClinicalTrials.gov record NCT05631197. Inclusion in this directory is not an endorsement.